Health
EnglishEli Lilly Aims to Make India Its Drug-Making Superstar
Eli Lilly, the mastermind behind Mounjaro, is setting its sights on India to become a global drug-making superstar! With a hefty $1 billion investment, they aim to turn India into a supply chain sensation. Their weight-loss drug is flying off the shelves, tapping into the growing demand for obesity treatments in a country that’s projected to have a lot of folks needing help by 2050.
few hours ago | Reuters
Quick rundown
1.Eli Lilly aims to make India a global supply chain hub.
2.Mounjaro's sales skyrocketed in India, becoming the top-seller.
3.India is projected to have the second-largest obese population by 2050.
4.Eli Lilly plans to export drugs from India globally.
5.The company is investing $1 billion in India's contract manufacturing.
